Skip to main content
Fig. 7 | Journal of Translational Medicine

Fig. 7

From: Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies

Fig. 7

Multiplex cytokine analysis. Comparison of the mean serum levels of the cytokines, expressed in pg/ml, form healthy controls (light gray bars), from healthy controls (light gray bars), COVID-19 patients with normal FT3 serum levels (gray bars), from COVID-19 patients with low FT3 serum levels (dark gray bars) and from COVID-19 patients with hematological malignancy and with low FT3 levels (black bars). a IL-1b = interleukin 1 beta; b IL-1ra = interleukin-1 receptor antagonist; c IL-6 = interleukin 6; d IP-10 = interferon gamma-induced protein 10, also known as CXCL10; e MCP-1 = monocyte chemoattractant protein-1, also known as CCL2; f MIP-1a = macrophage inflammatory proteins-1a

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us